We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+3.56%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.99B
AUM Growth
-$200M
Cap. Flow
-$628M
Cap. Flow %
-12.59%
Top 10 Hldgs %
53.63%
Holding
424
New
126
Increased
60
Reduced
38
Closed
165
Avg Time Held Equity + Options
1.8 quarters
Top 10 Avg Time Held Equity + Options
1.4 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
1.9 quarters
Top 10 Avg Time Held Equity only
1.4 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Top Buys

Rank Stock Value
1
ANDV
Andeavor
ANDV
+$273M
2
XL
XL Group Ltd.
XL
+$104M
3
ESRX
Express Scripts Holding Company
ESRX
+$97.2M
4
EVHC
Envision Healthcare Holdings Inc
EVHC
+$88.3M
5
CI icon
Cigna
CI
+$69.2M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$526M
2
TWX
Time Warner Inc
TWX
+$279M
3
AET
Aetna Inc
AET
+$126M
4
MSCC
Microsemi Corp
MSCC
+$48.9M
5
MHK icon
Mohawk Industries
MHK
+$44.9M

Sector Composition

Rank Sector Weight
1 Financials 21.62%
2 Technology 20.95%
3 Industrials 12.75%
4 Miscellaneous 12.61%
5 Communication Services 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ENDP
176
PUT
DELISTED
Endo International plc
ENDP
$1.22M 0.02%
+2,020,500
New +$13.6M
2018 Q2
0 quarters
ESS icon
177
Essex Property Trust
ESS
$17.5B
$1.22M 0.02%
+5,100
New +$1.21M
2018 Q2
0 quarters
MAC icon
178
Macerich
MAC
$6.31B
$1.22M 0.02%
+21,400
New +$1.21M
2018 Q2
0 quarters
KURA icon
179
Kura Oncology
KURA
$943M
$1.2M 0.02%
66,157
-4,100
-6% -$69.4K
2018 Q1
1 quarter
URGN icon
180
UroGen Pharma
URGN
$1.8B
$1.13M 0.02%
+22,659
New +$1.32M
2018 Q2
0 quarters
SMPL icon
181
CALL
Simply Good Foods
SMPL
$901M
$1.13M 0.02%
270,000
-7,860
-3% -$105K
2017 Q3
3 quarters
ITRM icon
182
DELISTED
Iterum Therapeutics
ITRM
$1.09M 0.02%
+6,667
New +$1.2M
2018 Q2
0 quarters
KIN
183
DELISTED
Kindred Biosciences, Inc.
KIN
$1.06M 0.02%
+100,000
New +$975K
2018 Q2
0 quarters
HYG icon
184
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.3B
$1.04M 0.02%
1,500,000
– –
2017 Q2
4 quarters
NSLR icon
185
Neostellar Capital Corp
NSLR
$192M
$1.03M 0.02%
+178,692
New +$1.05M
2018 Q2
0 quarters
SKT icon
186
Tanger
SKT
$4.03B
$1.03M 0.02%
+43,700
New +$961K
2018 Q2
0 quarters
VCEL icon
187
Vericel Corp
VCEL
$2.05B
$913K 0.02%
+94,150
New +$1.17M
2018 Q2
0 quarters
TSLA icon
188
PUT
Tesla
TSLA
$1.51T
$867K 0.02%
+483,000
New +$9.82M
2018 Q2
0 quarters
AKAO
189
DELISTED
Achaogen Inc
AKAO
$866K 0.02%
+100,000
New +$1.22M
2018 Q2
0 quarters
DNTH icon
190
Dianthus Therapeutics
DNTH
$4.61B
$810K 0.02%
+3,750
New +$846K
2018 Q2
0 quarters
EA icon
191
CALL
DELISTED
Electronic Arts
EA
$793K 0.02%
938,600
-101,400
-10% -$13.2M
2018 Q1
1 quarter
FTR
192
PUT
DELISTED
Frontier Communications Corp.
FTR
$783K 0.02%
+405,000
New +$3.3M
2018 Q2
0 quarters
ADT icon
193
ADT
ADT
$4.7B
$778K 0.02%
+90,000
New +$747K
2018 Q2
0 quarters
GFF icon
194
Griffon
GFF
$4.1B
$740K 0.01%
+41,595
New +$856K
2018 Q2
0 quarters
GPRO icon
195
GoPro
GPRO
$246M
$644K 0.01%
+100,000
New +$557K
2018 Q2
0 quarters
CDP icon
196
COPT Defense Properties
CDP
$3.8B
$638K 0.01%
22,000
-25,800
-54% -$707K
2018 Q1
1 quarter
ESRT icon
197
Empire State Realty Trust
ESRT
$802M
$617K 0.01%
36,100
-110,200
-75% -$1.86M
2018 Q1
1 quarter
APPN icon
198
Appian
APPN
$2.87B
$595K 0.01%
16,461
-93,338
-85% -$2.89M
2018 Q1
1 quarter
NVR icon
199
NVR
NVR
$15.7B
$594K 0.01%
+200
New +$612K
2018 Q2
0 quarters
WH icon
200
Wyndham Hotels & Resorts
WH
$5.5B
$588K 0.01%
+10,000
New +$616K
2018 Q2
0 quarters
6 7
8
9 10

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2018 Portfolio in Review

As of Q2 2018, UBS O'Connor held 424 positions worth $4.99B, down 3.9% from $5.19B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

UBS O'Connor withdrew a net $628M in Q2 2018, closing 165 positions and reducing 38 holdings. Its most notable exit was Monsanto Co, an estimated $526M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

Against the trend, UBS O'Connor opened a new position in Envision Healthcare Holdings Inc worth $94.6M.

  • UBS O'Connor's largest Q2 2018 buy was Envision Healthcare Holdings Inc: 2,150,000 shares worth $94.6M.
  • UBS O'Connor added most to Andeavor in Q2 2018, an estimated $273M increase.
  • UBS O'Connor's biggest Q2 2018 reduction was Aetna Inc, cutting an estimated $126M.
  • UBS O'Connor fully exited Monsanto Co in Q2 2018, selling an estimated $526M.
  • UBS O'Connor's ten largest holdings make up 54% of its $4.99B portfolio in Q2 2018.
  • UBS O'Connor opened 126 new positions and closed 165 in Q2 2018.
  • UBS O'Connor's portfolio value fell 3.9% quarter-over-quarter to $4.99B.

Based on UBS O'Connor's 13F filing for Q2 2018, filed 14 Aug 2018.